Open samueljpearce opened 5 months ago
Cefazolin for Pasteurella multocida in dogs is also incorrectly given urinary and genital tract sites (should only be for skin, soft tissue and respiratory).
As mentioned in issue https://github.com/msberends/AMR/issues/141, the feline E. coli urinary tract breakpoint for ampicillin is missing from the clinical breakpoints dataset, even though it is in the 2023 CLSI VET01S document.
Apparently it is in the CLSI 2024 data that we imported from WHONET, but not in older guidelines. I'll check the other ones too.
As mentioned in issue #141, the feline E. coli urinary tract breakpoint for ampicillin is missing from the clinical breakpoints dataset, even though it is in the 2023 CLSI VET01S document.
I have just found that the clinical breakpoints dataset contains an extra breakpoint for dogs for Staphylococcus spp. and amoxicillin-clavulanate for urinary tract infections that does not exist in the 2023 CLSI VET01S document. These breakpoints are higher than the combined soft tissue and urinary tract infection breakpoint in the document.